Around the time that much of the United States was beginning to shut down in response to COVID-19, President Trump nominated Dr. Nancy B. Beck for Commissioner and Chairman of the Consumer Product Safety Commission (CPSC). A review of Dr. Beck’s education and background shows that the vast majority of her career – over 15 years – has been spent in public service. Yet Dr. Beck’s nomination has been met with criticism of her roughly five years as a Director at the American Chemistry Council (ACC). For instance, the Chair of the House Energy and Commerce Committee issued a press release which highlighted Dr. Beck’s time at the ACC and claimed that Dr. Beck was “doing the bidding of the chemical industry at the expense of the health and safety of the American public.” Likewise, the Washington Post and New York Times headlined articles about Dr. Beck with a description of her as a “chemical industry executive.” While it may be expected that Dr. Beck’s detractors would focus on her time at the ACC, media characterizations of her as a “chemical industry executive” do not accurately describe the whole of her professional efforts.

Continue Reading